Class I HDAC Inhibitor Improves Synaptic Proteins and Repairs Cytoskeleton Through Regulating Synapse-Related Genes In vitro and In vivo

β-amyloid (Aβ) is an important protein molecule in the pathology of Alzheimer’s disease (AD). Accumulation of Aβ leads to the loss of dendritic spines and synapses. These impairments can be ameliorated by histone deacetylase inhibitors (HDACI). However, the mechanisms of HDACIs underlying the effect...

Full description

Bibliographic Details
Main Authors: Ying Han, Le Chen, Yu Guo, Chunyang Wang, Chenghong Zhang, Li Kong, Haiying Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2020.619866/full
_version_ 1818425073236705280
author Ying Han
Le Chen
Yu Guo
Chunyang Wang
Chenghong Zhang
Li Kong
Haiying Ma
author_facet Ying Han
Le Chen
Yu Guo
Chunyang Wang
Chenghong Zhang
Li Kong
Haiying Ma
author_sort Ying Han
collection DOAJ
description β-amyloid (Aβ) is an important protein molecule in the pathology of Alzheimer’s disease (AD). Accumulation of Aβ leads to the loss of dendritic spines and synapses. These impairments can be ameliorated by histone deacetylase inhibitors (HDACI). However, the mechanisms of HDACIs underlying the effect on synapse are not fully understood. In this study, we examined the relationship between HDAC activity and synapse-related genes and proteins by the administration of a class I HDAC inhibitor, BG45, in the exogenous Aβ-treated cells and mice. Our studies showed that the treatment of HF-488-Aβ1–42 to SH-SY5Y cells first increased the expression of the postsynaptic dendritic protein (PSD), then decreased it after 36 h. BG45 can alleviate the reduction of the expression of PSD-95 as well as spinophilin and cytoskeletal protein induced by HF-488-Aβ1–42 aggregation in SH-SY5Y cells. Similar to the results in vitro, PSD-95 in the hippocampus was temporarily increased in the early days of intravenous injection HF-488-Aβ1–40 to the mice, followed by the decreased expression of PSD-95 on the 9th day. In further studies, for the mice treated with Aβ for 9 days, we found that BG45 decreased the expression of HDAC1 and 2, increased the expression of PSD-95, spinophilin, and synaptophysin (SYP). Our data also showed that BG45 upregulated levels of three synapse-related genes and proteins GRIK2, SCN3B, and SYNPR. These findings suggest that the exogenous Aβ may stimulate transiently the expression of PSD-95 at an early stage, but subsequently contribute to synaptic defects. HDAC1 and 2 are involved in synaptic defects, and BG45 may improve the expression of synaptic and cytoskeletal proteins and repair cytoskeletal damage by specifically inhibiting HDAC1 and 2, thereby modulating synapse-related genes. BG45 might be a potential therapeutic agent for the treatment of an early stage of Aβ-related neurodegenerative disease.
first_indexed 2024-12-14T14:08:08Z
format Article
id doaj.art-7effe517864746a8845edbf2d8d3914f
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-12-14T14:08:08Z
publishDate 2021-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-7effe517864746a8845edbf2d8d3914f2022-12-21T22:58:24ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652021-01-011210.3389/fnagi.2020.619866619866Class I HDAC Inhibitor Improves Synaptic Proteins and Repairs Cytoskeleton Through Regulating Synapse-Related Genes In vitro and In vivoYing HanLe ChenYu GuoChunyang WangChenghong ZhangLi KongHaiying Maβ-amyloid (Aβ) is an important protein molecule in the pathology of Alzheimer’s disease (AD). Accumulation of Aβ leads to the loss of dendritic spines and synapses. These impairments can be ameliorated by histone deacetylase inhibitors (HDACI). However, the mechanisms of HDACIs underlying the effect on synapse are not fully understood. In this study, we examined the relationship between HDAC activity and synapse-related genes and proteins by the administration of a class I HDAC inhibitor, BG45, in the exogenous Aβ-treated cells and mice. Our studies showed that the treatment of HF-488-Aβ1–42 to SH-SY5Y cells first increased the expression of the postsynaptic dendritic protein (PSD), then decreased it after 36 h. BG45 can alleviate the reduction of the expression of PSD-95 as well as spinophilin and cytoskeletal protein induced by HF-488-Aβ1–42 aggregation in SH-SY5Y cells. Similar to the results in vitro, PSD-95 in the hippocampus was temporarily increased in the early days of intravenous injection HF-488-Aβ1–40 to the mice, followed by the decreased expression of PSD-95 on the 9th day. In further studies, for the mice treated with Aβ for 9 days, we found that BG45 decreased the expression of HDAC1 and 2, increased the expression of PSD-95, spinophilin, and synaptophysin (SYP). Our data also showed that BG45 upregulated levels of three synapse-related genes and proteins GRIK2, SCN3B, and SYNPR. These findings suggest that the exogenous Aβ may stimulate transiently the expression of PSD-95 at an early stage, but subsequently contribute to synaptic defects. HDAC1 and 2 are involved in synaptic defects, and BG45 may improve the expression of synaptic and cytoskeletal proteins and repair cytoskeletal damage by specifically inhibiting HDAC1 and 2, thereby modulating synapse-related genes. BG45 might be a potential therapeutic agent for the treatment of an early stage of Aβ-related neurodegenerative disease.https://www.frontiersin.org/articles/10.3389/fnagi.2020.619866/fullAlzheimer’s diseaseβ-amyloidHDAC inhibitorsynaptic proteincytoskeletal protein
spellingShingle Ying Han
Le Chen
Yu Guo
Chunyang Wang
Chenghong Zhang
Li Kong
Haiying Ma
Class I HDAC Inhibitor Improves Synaptic Proteins and Repairs Cytoskeleton Through Regulating Synapse-Related Genes In vitro and In vivo
Frontiers in Aging Neuroscience
Alzheimer’s disease
β-amyloid
HDAC inhibitor
synaptic protein
cytoskeletal protein
title Class I HDAC Inhibitor Improves Synaptic Proteins and Repairs Cytoskeleton Through Regulating Synapse-Related Genes In vitro and In vivo
title_full Class I HDAC Inhibitor Improves Synaptic Proteins and Repairs Cytoskeleton Through Regulating Synapse-Related Genes In vitro and In vivo
title_fullStr Class I HDAC Inhibitor Improves Synaptic Proteins and Repairs Cytoskeleton Through Regulating Synapse-Related Genes In vitro and In vivo
title_full_unstemmed Class I HDAC Inhibitor Improves Synaptic Proteins and Repairs Cytoskeleton Through Regulating Synapse-Related Genes In vitro and In vivo
title_short Class I HDAC Inhibitor Improves Synaptic Proteins and Repairs Cytoskeleton Through Regulating Synapse-Related Genes In vitro and In vivo
title_sort class i hdac inhibitor improves synaptic proteins and repairs cytoskeleton through regulating synapse related genes in vitro and in vivo
topic Alzheimer’s disease
β-amyloid
HDAC inhibitor
synaptic protein
cytoskeletal protein
url https://www.frontiersin.org/articles/10.3389/fnagi.2020.619866/full
work_keys_str_mv AT yinghan classihdacinhibitorimprovessynapticproteinsandrepairscytoskeletonthroughregulatingsynapserelatedgenesinvitroandinvivo
AT lechen classihdacinhibitorimprovessynapticproteinsandrepairscytoskeletonthroughregulatingsynapserelatedgenesinvitroandinvivo
AT yuguo classihdacinhibitorimprovessynapticproteinsandrepairscytoskeletonthroughregulatingsynapserelatedgenesinvitroandinvivo
AT chunyangwang classihdacinhibitorimprovessynapticproteinsandrepairscytoskeletonthroughregulatingsynapserelatedgenesinvitroandinvivo
AT chenghongzhang classihdacinhibitorimprovessynapticproteinsandrepairscytoskeletonthroughregulatingsynapserelatedgenesinvitroandinvivo
AT likong classihdacinhibitorimprovessynapticproteinsandrepairscytoskeletonthroughregulatingsynapserelatedgenesinvitroandinvivo
AT haiyingma classihdacinhibitorimprovessynapticproteinsandrepairscytoskeletonthroughregulatingsynapserelatedgenesinvitroandinvivo